E
Genix Pharmaceuticals Corporation GENPF
$0.0138 -$0.0262-65.50% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

04/30/2025 01/31/2025 10/31/2024 07/31/2024 04/30/2024
Revenue -- -- 100.00 700.00 2.10K
Total Other Revenue -- -- -- -- --
Total Revenue -- -- 100.00 700.00 2.10K
Cost of Revenue -- -- 134.10K 300.00 1.00K
Gross Profit -- -- -134.00K 500.00 1.20K
SG&A Expenses 21.90K 21.30K 44.80K 30.00K 29.30K
Depreciation & Amortization 200.00 200.00 200.00 200.00 200.00
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 22.10K 21.50K 179.10K 30.50K 30.50K
Operating Income -22.10K -21.50K -179.00K -29.80K -28.30K
Income Before Tax -36.60K -75.50K 112.80K -60.00K -63.30K
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -36.60K -75.50K 112.80K -60.00K -63.30K
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -36.60K -75.50K 112.80K -60.00K -63.30K
EBIT -22.10K -21.50K -179.00K -29.80K -28.30K
EBITDA -21.90K -21.30K -79.00K 69.30K -28.10K
EPS Basic 0.00 0.00 0.00 0.00 0.00
Normalized Basic EPS 0.00 0.00 0.00 0.00 0.00
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Normalized Diluted EPS 0.00 0.00 0.00 0.00 0.00
Average Basic Shares Outstanding 59.22M 59.22M 59.22M 59.22M 59.22M
Average Diluted Shares Outstanding 59.22M 59.22M 59.22M 59.22M 59.22M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --